NLRP3 inhibitor Oridonin can suppress the expression of IL-18 and IL-1, alleviate inflammation, preserve myocardial function and improve myocardial remodeling by reducing NLRP3 expression [89]
However, prescribers must be aware that the FDA issued a safety alert in April 2025 specifically addressing compounded topical finasteride
Guan Y, Niu H, Wen J, Dang Y, Zayed M, Guan J
For this issue, other than traditional pharmacological ovarian suppression such as goserelin, 499 patients can also receive a diet that is beneficial to their reproductive organs while avoiding behaviors that are harmful to reproductive health, such as smoking and drinking
Horizant is FDA-approved for PHN at a dose of 600 mg twice daily (started at once daily, then titrated), providing significant pain reduction in clinical trials